Medically reviewed by Christopher Lee, MD Treatment for ATTR-CM has historically been symptom management. However, until 2019, the United States Food and Drug Administration (FDA) did not approve any ...

About 10 million people worldwide are living with Parkinson's, which usually appears after age 60. What to know about the ...

Among patients with T2D and DPN, some with nonpainful DPN developed neuropathic pain over a 5-year period while others with painful DPN experienced relief.

A recent study linking human pegivirus to Parkinson’s is leading scientists to examine the connection between other viral ...

Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for ...

While it is not a common condition, Guillain-Barré Syndrome (GBS) is garnering increased interest from the broader medical diagnostics industry as new cases are reported worldwide each year and linked ...

Lorena Bobbitt cut off her husband John Bobbitt's penis in 1993 after he allegedly raped her. Here’s everything to know about ...

VYVGART is the first and only targeted IgG Fc-antibody fragment for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and the first novel mechanism of action for CIDP treatment in more than ...

Objective To elucidate the long-term effects of liver transplantation (LT) on familial amyloid polyneuropathy (FAP). Methods We investigated clinicopathological and biochemical characteristics of ...

1. Neuropathic pain in diabetic polyneuropathy is dynamic over time, with distinct clinical and sensory predictors associated with both its development and resolution. Evidence Rating Level: 2 (Good) ...

There’s no test to tell you if you have chronic inflammatory demyelinating polyneuropathy (CIDP). Its symptoms are similar to Guillain-Barre syndrome, but unlike GBS, those symptoms. If you’ve ...

Netherlands-based argenx has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended its efgartigimod alfa treatment, brand name ...